Sunesis Pharmaceuticals, Inc. (SNSS) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bullish

100% of 2 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Netteligent Netteligent 10/16/2014 3 months $1.24 $2.12 +70.97% 70 Active
Comments:
kesiki kesiki 10/07/2014 3 months $1.46 $2.12 +45.21% 45 Active
Comments:
JOKER66 JOKER66 09/11/2012 1 day $2.64 $3.80 +43.94% 43 Ended
Comments: Industry sector growing or poised for growth
jesus_3 jesus_3 04/04/2012 3 months $2.91 $3.10 +6.53% 6 Ended
Comments: Industry sector growing or poised for growth
Rick_49 Rick_49 11/29/2010 3 months $0.39 $2.95 +655.83% 655 Ended
Comments: BUY. BUY. BUY. Great prod in pipeline. Phase 3 n over $2, analyst ests over $2
Nichols.wk Nichols.wk 08/10/2010 3 months N/A Ended
Comments:
TjVd TjVd 07/27/2010 3 months N/A Ended
Comments: ,Phase 3 above $1
YCBIG1 YCBIG1 04/05/2010 3 months N/A Ended
Comments: Buy out on the way.
SLRtrades SLRtrades 04/02/2010 3 months N/A Ended
Comments: Excellent product pipeline, with two completely phase II studies. This is the time to get into this stock.
Luís Neves Luís Neves 02/16/2010 3 months N/A Ended
Comments:
nahk nahk 01/27/2010 3 months N/A Ended
Comments: SNSS has gone down for 5 days. This should go up tomorrow i.e., 28/1/2010
GenLI GenLI 01/26/2010 3 months N/A Ended
Comments: its going down
moe1 moe1 12/07/2009 3 months N/A Ended
Comments:

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.